CRL
NYSE
$219.57
Charles River Laboratories International Inc (CRL)
Charles River Laboratories International, Inc., is an American pharmaceutical company specializing in a variety of preclinical and clinical laboratory, gene therapy and cell therapy services for the Pharmaceutical, Medical device and Biotechnology industries. It also supplies assorted biomedical products and outsourcing services for research and development in the pharmaceutical industry and offer support in the fields of basic research, drug discovery, safety and efficacy, clinical support, and manufacturing.
Sector:
Healthcare
Industry:
Diagnostics & Research
Buy
Target: $230.93 (+5.17%)
Market Cap
$11B
FCF 5Y CAGR
+42.96%
Free Cash Flow Yield
5.52%
Beta (5Y)
1.38
Price Chart
Valuation
Market Cap$11B
Forward P/E20.16
P/S2.77
P/B3.76
Profitability
Total Revenue (TTM)$4.03B
Gross Profit (TTM)$1.39B
EBITDA$420M
Profit Margin-1.5%
Operating Margin12%
EPS-$3.76
Financial Health
Debt-to-Equity0.2%
Free Cash Flow Yield5.52%
Growth & Risk
Revenue 5Y CAGR+5.77%
FCF 5Y CAGR+42.96%
Beta (5Y)1.38
Sharpe Ratio0.88